Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday

The company doesn't seem like it will generate pops in key fundamentals anytime soon.
Fintel on MSN

Wells Fargo Maintains Bio-Rad Laboratories (BIO.B) Equal-Weight Recommendation

Fintel reports that on October 30, 2025, Wells Fargo maintained coverage of Bio-Rad Laboratories (NYSE:BIO.B) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 21.85% Upside As of ...
Yahoo Finance

Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays

LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which ...

Bio-Rad: Q3 Earnings Snapshot

Bio-Rad Laboratories Inc. (BIO) on Wednesday reported a third-quarter loss of $341.9 million, after reporting a profit in the same period a ...
Insider Monkey

Bio-Rad (BIO) Surged as the Earnings Exceeded Expectations

Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” third-quarter 2025 investor letter. The letter can be downloaded here. The fund returned -0.33% in the third ...
Mena FN

Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement To Develop Droplet Digitaltm PCR High Complexity Assays

(MENAFN- GlobeNewsWire - Nasdaq) Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE ...
Hosted on MSN

Bio-Rad Laboratories (BIO) Q3 Earnings Miss Estimates

Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.26 per share, missing the Zacks Consensus Estimate of $2.3 per share. This compares to earnings of $2.01 per share a year ago. These ...
Investing

Entera Bio stock rises after positive Phase 2 bone density data

Investing.com -- Entera Bio Ltd. (NASDAQ:ENTX) stock rose 3.5% in Thursday’s premarket trading following the company’s presentation of new clinical data from its Phase 2 trial of EB613, an oral ...
Island

Lotus Group cultivates export future with pioneering bio-tech lab

In a significant boost to Sri Lanka’s agri-tech ambitions, the Lotus Group of Companies has launched the nation’s first private, export-oriented tissue culture laboratory, positioning the island to ...
Yahoo Finance

Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women

JERUSALEM, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported new clinical data from a post ...
Investing

BioNexus Gene Lab enters strategic partnership talks with BirchBioMed

KUALA LUMPUR - BioNexus Gene Lab Corp (NASDAQ:BGLC), a $9.22 million market cap diagnostics company with annual revenues of $9.55 million, announced Monday it has entered into a non-binding strategic ...